| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |